Generic cholesterol drug shows promise in small bioequivalence trial
NCT ID NCT07170852
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 29 times
Summary
This study compared a generic bempedoic acid tablet to the brand-name drug Nilemdo in 32 healthy adults. Participants took a single dose under fasting conditions to see if the generic version reaches similar levels in the blood. The goal was to confirm the generic works the same way, which could offer a more affordable treatment option for high cholesterol.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLAEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cliantha Research Limited
Noida, 201301, India
Conditions
Explore the condition pages connected to this study.